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doi:10.1016/j.ejvs.2009.12.025Abstract Introduction: Recanalisation rates (20e32%) 1e3 years after truncal vein foam
sclerotherapy (FS) suggest thrombotic occlusion rather than irreversible vein wall injury. This
study examines the injury inflicted by sodium tetradecyl sulphate (STD) foam before and after
balloon endothelial denudation (BD).
Methods: In 20 patients undergoing great saphenous vein (GSV) stripping 1.5 cm proximal GSV
were harvested (controls). The next 1.5 cm were harvested after in situ BD (n Z 10) or no
denudation (nZ 10). These test segments were filled with 1% or 3% STD foam (5 min), flushed
and fixed in formalin. Percentage endothelial cell loss (ECL) and tunica media injury were
determined (H&E staining) and collagen structure assessed (transmission electron microscopy,
TEM).
Results: Controls showed no injury. 1% and 3% STD foam caused 86.3% and 92.2% ECL (p < 0.001
versus controls; 1% versus 3%, p Z 0.55). Endothelial cells persisted in all sections. BD
increased ECL (1%: 96.9%, 3%: 98.1%, p Z 0.01)
Tunica media injury (smooth muscle vacuolation) was minimal (8.9% (1% STD) and 12% (3%
STD) of its depth) and not enhanced by BD (1%: 8.7%, p Z 0.93; 3%: 11.3%; p Z 0.86). No
collagen disruption occurred (TEM).
Conclusions: Balloon denudation increased ECL but did not facilitate tunica media injury.
Equivalent injury was inflicted by 1% and 3% STD.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.ting 3e6 September, 2009, European Society for Vascular Surgery, Oslo, Norway.
edsth.nhs.uk (M.J. Gough).
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The development of minimally invasive techniques for the
treatment of varicose veins is driven by the aims of
achieving results equivalent or superior to surgery whilst
minimising complications and encouraging an earlier return
to normal activities. Whilst radiofrequency and endovenous
laser ablation demonstrate short and medium term
outcomes comparable with conventional surgery,1e3 foam
sclerotherapy for incompetent truncal varicosities is asso-
ciated with disappointing short term recanalisation rates of
20e32%4,5 which is implicated in the development of clin-
ical recurrence.6 There are few studies addressing this issue
and assessing the histological changes that occur in human
vein following foam sclerotherapy. One previous qualitative
study only describes gross histological changes but does not
quantify the extent of endothelial injury or depth of vein
wall damage.7
It is possible that after thrombotic occlusion at the time
of sclerotherapy residual endothelial cells promote recan-
alisation in the same way as it might occur after a deep vein
thrombosis.8 This is likely to be followed by recurrent
truncal vein incompetence and the re-appearance of
varicosities.
The technique of balloon catheter injury has been shown
to denude the endothelium9 and the hypothesis for this
study was that mechanical removal of this regenerative
layer prior to application of foam STD might enhance the
injury sustained by the vein wall following application of
sclerosant and reduce the capacity for recanalisation.
Further, the efficacy of two different concentrations of
sclerosant (STD) has been assessed.Methods
Tissue harvesting
Twenty patients with primary varicose veins secondary to
sapheno-femoral junction (SFJ) and great saphenous vein
(GSV) incompetence were recruited. At the time of SFJ
ligation, 1.5 cm of proximal GSV was harvested to act as
control vein (control segments). These segments were not
subject to any further intervention.
In 10 patients, the GSV underwent in situ balloon
denudation. In order to achieve this, the GSV was marked
pre-operatively at the level of the knee using ultrasound.
During surgery the marked GSV was exposed through a 5
mm incision and a 5F Fogarty catheter (Le Maitre Vascular
Inc, Sulzbach, Germany) advanced proximally. The balloon
was inflated and five passes of the proximal GSV were
performed. In these, and the other 10 patients the next 1.5
cm of GSV were harvested (test segments).
Informed consent was obtained from all patients
participating in the study. Ethical approval was granted by
the local research and ethics committee.
Exposure to STD foam
After excision the control and test segments (10 balloon
denuded, 10 no balloon) of vein were placed in separategallipots containing cell culture medium M199 (Sigmae
Aldrich, St Louis, USA) supplemented with penicillin 5000
units/ml, streptomycin 5000 mg/ml, amphotericin B 250 mg/
ml (Invitrogen Ltd, Paisley, UK) and fetal calf serum 2%
(Promocell, Germany). The test segments were filled with
1% or 3% STD foam produced at a 1:3 liquid to air ratio using
the Tessari technique,10 introduced directly from the
syringe using a shortened 20 G intravenous cannula. The
investigator was blinded to the concentration of foam used.
Foam was retained in the vein by application of a Vascu-
Statt clamp (Scanlan International, Saint Paul, USA) at
each end of the vein. After 5 min, the clamps were removed
and the STD was washed out with 5 ml autologous blood,
introduced via a shortened 20 G intravenous cannula. A
fixed contact time of 5 min was employed as the half life of
1% and 3% STD is 181 and 217 s respectively, with the foam
completely reverting to liquid by 300 s (authors’ unpub-
lished data).
Histological analysis
Both control and test segments were pinned on mounting
card to prevent vein contraction during the fixing process
and placed in 10% formal saline.
Light microscopy
After at least 7 days of fixation sections were isolated for
separate histological staining and transmission electron
microscopy. Sections from each specimen underwent (i)
Haemotoxylin & Eosin (H&E) staining to demonstrate over-
all vein architecture; (ii)Van Geison staining to highlight
elastin fibres, and (iii) Picrosirius Red staining to specifically
aid the demonstration of collagen.
The processed H & E sections were digitally scanned with
a pathology software package (Aperio Imagescope version
9.1.19.1 2006, Aperio Technologies, Vista, California) to
produce images for subsequent observer blinded analysis.
These images allowed simultaneous inspection and
measurement of areas of interest.
Transmission electron microscopy (TEM)
The specimens saved for TEM were used for ultrastructural
analysis of collagen at the following depths: intima, media
and adventitia. Processed ultrathin sections were viewed
using a CM10 microscope (Philips, Best, Netherlands) and
electronmicrographs taken at 80 kV with a magnification of
18,000e24,000.
Outcome measures
The outcome measures determined were (i) extent of
persisting endothelial cell coverage (ii) the presence and
depth of vein wall injury (iii) the integrity of collagen
fibrils. Reproducibility of the measurement techniques was
assessed by comparison of inter- and intra-observer
measurements. For each specimen two transverse sections
underwent examination. The extent of endothelial cell
coverage was determined by first measuring the total
luminal circumference (Fig. 1a). The intima was then
closely inspected and intact, densely stained endothelial
cells that remained in contact with the basement were
Figure 1 a: H&E stained transverse section of GSV. Lumen outlined to allow measurement of luminal circumference, b: Intact
endothelium marked to allow determination of endothelial cell coverage as a proportion of the total luminal circumference. Scale
bars represent 100 mm.
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thelial cell loss (ECL) calculated (Fig. 1b).
In order to ascertain the depth of vein wall injury the
width of the tunica media was measured. This was defined
as the point from the lumen to the outer layer of smooth
muscle. Twelve measurements were taken per section,
evenly spaced around the circumference of the intima
(Fig. 2a). This approach was used as the intima and tunica
media are the most constant structures, whilst the internal
elastic lamina may be absent in places and the edge of the
adventitia may be partially removed during vein harvesting.
The percentage depth of injury was then established by
measuring the depth that sub-endothelial vacuolation
extended from the intima (vein lumen). These changes are
characterised by swollen, pale smooth muscle cells, with an
unravelling nucleolus, as opposed to the densely stained,
small nuclei exhibited by normal cells. It is important toFigure 2 a: H&E stained transverse section of GSV demonstrati
box), b: Measurement of sub-endothelial vacuolation within the tuquantify the injury sustained by smooth muscle cells as this
potentially represents collagen damage within that region.
At each tunica media measurement, the depth of injury
was established and 3 measurements taken (Fig. 2b). The
mean tunica media width and mean depth of injury was
derived for each transverse section. The percentage depth
of injury was then calculated. The mean percentage depth
of injury for each experimental group was obtained from
the mean of the combined results of the sections repre-
senting the group.
Statistical analysis
Data are shown as the mean  SD. Analysis was performed
using SPSS version 16.0 (Statistical Package for Social
Sciences Inc, Chicago, Illinois, USA). The Mann Whitney U
test was used to assess differences in the depth of injuryng measurement of the thickness of the tunica media (yellow
nica media (blue boxes).
Table 2 Percentage tunica media injury following expo-





(Mann Whitney U)No Yes
1 8.9 (1.4) 8.7 (3.5) 0.93
3 12 (6.4) 11.3 (2.7) 0.86
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and variability between inter and intra-observer scores
were studied using the BlandeAltman plot and paired t
test. A p value 0.05 was considered significant.
Results
Endothelial cell coverage
Control samples demonstrated largely preserved intima
with a mean ECL of 6.61% (1.35). Following exposure to 1%
and 3% STD for 5 min, ECL was 86.3% (6.48) and 92.2%
(2.82) respectively. Although areas of basement
membrane detachment were evident, foci of endothelial
cells remained visible in all sections. Although a greater
reduction in intimal coverage was evident following expo-
sure to 3% STD this difference was not significant (p Z
0.55). Balloon denudation increased ECL for both 1% and 3%
STD (96.9% (0.60) and 98.1% (0.72) respectively). This
was significant (p < 0.01) when compared with the non-
denuded group (Table 1). Nevertheless islands of endothe-
lial cells were again visible in all specimens.
Tunica media injury
Sub-intimal injury (smooth muscle vacuolation) was patchy
and superficial and was confined to the inner media. It
extended for 8.9% (1% STD) and 12% (3% STD) of media
depth in non-denuded vein and was not enhanced by
balloon denudation (Table 2). Elastin and collagen
remained intact on examination of sections subject to
specific stains. Similarly, well defined, ordered collagen
bundles were demonstrated at all depths of the tunica
media on TEM (Fig. 3aec). Using this technique it was again
evident that smooth muscle injury was confined to the
innermost sections.
Reproducibility
There was no evidence of significant inter or intra-observer
variation. The range of measurements between observers
was within 10%, demonstrating minimal spread. Comparison
of paired measurements did not reveal any significant
difference (inter-observer p Z 0.749, intra-observer p Z
0.515).
Discussion
Many years have elapsed since Fegan first popularised the
treatment of varicose veins with injection sclerotherapy.11Table 1 Percentage endothelial cell loss following expo-








1 86.3 (6.48) 96.9 (0.60) <0.01
3 92.2 (2.82) 98.1 (0.72) <0.01More recent developments, aimed at reducing recurrence
rates following this have focussed on the treatment of
incompetent truncal veins (rather than the superficial
varicosities) using foam rather than liquid sclerosants with
the aim of achieving permanent occlusion. However ultra-
sound follow-up of patients treated with this modality has
shown recanalisation and recurrent reflux in 20e32% of
limbs at 1e3 years,4,5 compared with rates of 1e16% in
those treated with EVLA and RF.12
For minimally invasive varicose vein therapies to be
successful in the longer term it seems logical to suggest
that the treatment should inflict a full thickness injury to
the media (denaturing of collagen) which results in
permanent fibrosis of the treated vein. Indeed several
studies have suggested that this is a key aspect of tissue
welding and vessel closure.13,14 Further, both endovenous
laser and radiofrequency ablation induce heat-dependent
changes in the structure of collagen in the vein wall with
loss of periodicity, dissolution and fusion of fibres.15,16
These features are associated with fibre shortening and
vessel contraction.17 Nevertheless, application of insuffi-
cient energy to the vein wall with these techniques is
associated with failure to achieve permanent ablation of
the treated vein.18
In contrast there are few studies that have examined the
pathological effects of foam sclerotherapy on vein wall
integrity and none have explicitly quantified the injury
sustained. In an earlier study Orsini examined sections of
vein wall that had been exposed to STD, describing changes
similar to those of the current study with endothelial cell
loss and sub-endothelial oedema.7 However the extent of
injury was not quantified and any effect upon collagen was
not examined. Nevertheless it seemed likely that the
damage inflicted by STD was relatively superficial. In the
current study we have developed a reproducible technique
for quantification of endothelial and smooth muscle cell
injury in a model of foam sclerotherapy and used this to
quantify the extent of vein wall damage caused by two
different concentrations of the sclerosant. In addition
attempts were made to enhance the depth of injury by
denuding the endothelium prior to application of the foam.
It is apparent however that all test veins demonstrated
persistent islands of endothelial cells even after initial
balloon denudation. In addition the depth of injury to the
tunica media was minimal and not altered by initial
destruction of the endothelium. Further, the architecture
of collagen within the media was preserved. This and the
presence of residual endothelial cells are likely to explain
the relatively high recurrence rates after foam scle-
rotherapy. Although these are significant it is nevertheless
the case that the majority of veins remain occluded in the
medium term after foam sclerotherapy and there are at
Figure 3 TEM images of cross sections of GSV following balloon denudation and exposure to 3% STD for 5 min a: sub-intima
demonstrating early injury and loss of smooth muscle cell (SMC) mitochondria but normal architecture of longitudinal collagen
fibrils (CL), b: media showing normal architecture of longitudinal collagen fibrils (CL), c: adventitia with normal longitudinal and
transverse (CT) collagen fibrils.
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acute changes in collagen have been shown in this study it
is possible that sclerotherapy might have an effect on this
in the longer term in vivo. Alternatively success may
depend on effective thrombosis of the vein and the absence
of a significant volume of endothelial cells to promote
either fibrinolysis (early failure) or subsequent remodelling
of the vein. If either of these is the case, then despite the
failure of initial endothelial balloon denudation to augment
the injury to the tunica media, it could have a positive
impact on the success of sclerotherapy in vivo. Further,
previous studies have shown that balloon injury impairs
endothelial-dependent vessel relaxation19,20 and promotes
vessel spasm which is likely to facilitate early vessel closure
following administration of foam sclerotherapy. Thus
further evaluation of this technique is required.
A further potential advantage of using a balloon catheter
as an adjunct to ultrasound guided foam sclerotherapy
(UGFS) is that it may minimise passage of sclerosant beyond
the sapheno-femoral or sapheno-popliteal junction
reducing the risk of deep vein thrombosis and other adverse
events whilst improving the uniformity of contact with the
endothelium.21
It is accepted that the ex vivo model used in the current
study does not fully reflect the clinical setting for foam
sclerotherapy and its long-term effects cannot be assessed.
As alluded to above the effects on vein wall structure
following thrombosis of the treated vein cannot be deter-
mined. Similarly, any interaction with blood and its
components cannot be assessed. Despite these limitations,
it is apparent that the foam sclerosant only inflicts super-
ficial injury to the vessel wall. Furthermore the degree of
ex vivo injury sustained may actually overestimate the in
vivo response as blood components tend to attenuate the
action of sclerosants.22
In summary, intra-luminal application of either 1% or 3%
STD foam to great saphenous vein segments in thismodelwas
associated with incomplete endothelial destruction and
minimal tunica media injury. If similar effects occur in vivo
then this could explain the lower efficacy of UGFS compared
with other endovenous techniques. Thus, although foam hasenhanced the clinical efficacy of sclerotherapy in the treat-
ment of truncal varicosities23 alternative strategies may be
required to maximise vein wall injury with this technique.
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